Aethon receives two prestigious awards for leadership.

Aethon receives two prestigious awards for leadership, growth and innovation Aethon is proud to end up being the recipient of two individual awards recognizing their leadership, growth and innovation. Pittsburgh Technology Council chosen Aethon as 'Innovator of the Year' on October 10 throughout their Tech 50 gala, 2013. Aethon was selected as successful in the Autonomous Navigation category by judges from the International Journal of Advanced Robotic Systems and the business enterprise and purchase community along with editors from Robotics Business Review and Robotics Tendencies. During the meeting, Aethon also shipped a keynote presentation discussing El Camino hospital and their execution of 20 TUG robots.Baseline characteristics in the two groups were similar . The median urinary albumin-to-creatinine ratio was 847 at enrollment; 662 patients got a urinary albumin-to-creatinine ratio of 1000 or more. Fewer sufferers in the combination-therapy group than in the monotherapy group could actually reach the entire target dose of lisinopril or placebo ; 89.6 percent of the patients in the combination-therapy group and 93.4 percent of the patients in the monotherapy group were acquiring at least 10 mg of lisinopril or placebo each day at the end of the dose-adjustment period. At the ultimate end of the study, 83.9 percent of patients in the monotherapy group and 79.3 percent of individuals in the combination-therapy group were acquiring at least 10 mg of lisinopril or placebo per day.

-->